Caspian Healthcare
All calculators

For doctors · Diabetes

Insulin start and switch planner

Starting doses for type 2 and type 1, titration by fasting readings, dose conversions between insulins, and the move from an IV infusion to injections. It ends with a card your patient takes home.

For registered medical practitioners. These are starting points from prescribing information and guidelines, with the source shown for each. Adjust to the person in front of you. Adults only: for children, work with a paediatric diabetes team. Nothing you enter leaves this device.

1. The patient

Diabetes type
Hypoglycaemia risk tick any that apply

2. What do you need?

Titration helper

Last 3 fasting readings mg/dL

Other diabetes medicines

MedicineWhen insulin starts
MetforminContinue.
SGLT2 inhibitorContinue. Explain the ketone risk if insulin is later cut sharply.
GLP-1 medicine or tirzepatideContinue. ADA 2026 prefers these before insulin, and recommends combining them with insulin when insulin is needed.
Sulfonylurea
DPP-4 inhibitorStop if a GLP-1 medicine is used. Otherwise it can continue with basal, and stops when insulin is intensified.
RepaglinideStop when mealtime insulin starts.
PioglitazoneMay lower insulin needs. Watch for fluid retention and weight gain. Avoid in heart failure.

3. The patient card

What your patient takes home: the plan from the tab above, how to adjust it, lows, sick days, pen technique and storage. Check it, then print.

Sources

  1. American Diabetes Association. Standards of Care in Diabetes 2026. Section 9: Pharmacologic approaches to glycemic treatment. Diabetes Care 2026;49(Suppl 1):S183–S215. Section 16: Diabetes care in the hospital. Diabetes Care
  2. Garg SK, et al. ATLAS: patient-led versus physician-led titration of insulin glargine in Asian patients. Endocr Pract 2015;21:143–157. Misra A, et al. India subanalysis. Diabetes Technol Ther 2019;21:656–664.
  3. Prescribing information: insulin glargine 100 and 300 units/mL, insulin degludec, insulin degludec/insulin aspart, biphasic insulin aspart 30, insulin icodec, inhaled insulin human (US labels via DailyMed; EU SmPCs via EMA).
  4. Primary Care Diabetes and Obesity Society, ABCD. Guidance on the discontinuation of insulin detemir, May 2026. Diabetes UK. News on the withdrawal of insulin detemir. Kocurek B, Cryar K. Insulin products switching guide for disaster response settings (ADA, 2022). Cardi-OH guide to therapeutic interchange of insulin products, 2025.
  5. Erukulapati RS, et al. Indian consensus on insulin intensification. Clin Diabetol 2024. Chawla R, et al. RSSDI insulin consensus. Int J Diabetes Dev Ctries 2019;39(Suppl 2).
  6. Cengiz E, et al. ISPAD Clinical Practice Consensus Guidelines 2024, Chapter 9: Insulin treatment.
  7. Schmeltz LR, et al. Conversion of intravenous insulin infusions to subcutaneously administered insulin glargine. Endocr Pract 2006;12:641–650.

Found an error? Write to info@caspianhealthcare.in.